ÃØÃÜÑо¿Ëù

Internal Server Error
Unlock full details of this profile with our freeÌýLiteÌý±è±ô²¹²Ô!
Sign Up and Get Free Access

Last updated:

About Global Cardiovascular Innovation Center

Global Cardiovascular Innovation Center, an accelerator and incubator program founded in 2007, is based in Cleveland, United States. With a presence in 4 countries, it has supported around 31 startups in sectors like Life Sciences, HealthTech. As of May 2025, Global Cardiovascular Innovation Center has witnessed 7 portfolio exits. Most notable companies in its portfolio include AtriCure, Enable Injections and Centerline Biomedical. The program primarily supports Grant (prize money) startups based in United States. Its latest investment was a $1.3M Seed round in Sense Neuro Diagnostics on Mar 13, 2017, which also saw participation from Queen City Angels and .
Key Metrics
Founded Year
2007
Location
Cleveland, United States
Portfolio Companies
Sectors of Investment
Stages of Investment
Grant (prize money), Seed &
Locations of Investment

Global Cardiovascular Innovation Center's Portfolio

Global Cardiovascular Innovation Center has a portfolio ofÌý31 companies.Ìý°Õ³ó±ð¾±°ùÌýlatest investmentÌýwas inÌýSense Neuro Diagnostics(Seed Round) on Mar 13, 2017.ÌýThey have hadÌý7 portfolio exits.ÌýMost notable exits includeÌýAkebia Therapeutics,ÌýAthersys andÌýAtriCure.

Global Cardiovascular Innovation Center's Investments by Stage

Global Cardiovascular Innovation Center has made 2 investments in Grant (prize money) stage with an average round size of $509K, 1 investment in Seed stage with an average round size of $1.3M, 1 investment in Series A stage with an average round size of $5M and 1 investment in Series B stage with an average round size of $22.2M.
Here are Global Cardiovascular Innovation Center's investments by stage:
Note: We have considered here, only first round of investments
Breakdown of Global Cardiovascular Innovation Center's investments by stage of entryGrant (prize money) (2)Seed (1)
Stage of entry
No. of Investments
Grant (prize money)
2
Seed
1
Series A
1
Series B
1

Global Cardiovascular Innovation Center's Investments by Sector

Global Cardiovascular Innovation Center has a diverse portfolio, with companies operating in the Life Sciences, High Tech, Internet of Things - Industry Applications and HealthTech. Notably, it has invested in 24 Enterprise (B2B) companies, 23 Tech companies, 6 Tech hardware companies and at least 1 company focusing on Social impact.
Here are Global Cardiovascular Innovation Center's investments by sector:
Note: We have considered here, only first round of investments
Breakdown of Global Cardiovascular Innovation Center's investments by sectorsLife Sciences (4)High Tech (3)
Sector
No. of Investments
Life Sciences
4
High Tech
3
Internet of Things - Industry Applications
2
HealthTech
1

Global Cardiovascular Innovation Center's Investments by Geography

Global Cardiovascular Innovation Center has made most investments in United States (4), followed by Israel where it has made 1 investment.
Here are Global Cardiovascular Innovation Center's investments by geography:
Note: We have considered here, only first round of investments
Breakdown of Global Cardiovascular Innovation Center's investments by countriesUnited States (4)Israel (1)
Country
No. of Investments
United States
4
Israel
1

Global Cardiovascular Innovation Center's recent investments

Global Cardiovascular Innovation Center has not made any investment in 2025 so far.
Here are the most recent investments by Global Cardiovascular Innovation Center:
Date
Company
Location
Round Details
Round Amount
Co-Investors
Mar 13, 2017
United States
Seed
$1.3M
Sep 15, 2016
United States
Series C
$10M
Feb 26, 2015
Israel
Series A
$5M
Aug 08, 2012
United States
Series B
$22.2M
2011
United States
Grant (prize money)
Undisclosed
-

IPOs and Publicly Listed companies in Global Cardiovascular Innovation Center's Portfolio

3 of Global Cardiovascular Innovation Center's portfolio companies have become public.ÌýAkebia Therapeutics got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ), in Mar 2014 at marketcap of $328MÌýand Athersys got listed on the OTC Markets (OTCMKTS).
Here are Global Cardiovascular Innovation Center's portfolio companies that went public:
Company
IPO Date
First Invested on
First Round of Investment
Round Size
Mar 20, 2014
-
-
-
Jun 12, 2007
-
-
-
Aug 05, 2005
-
-
-

Acquired companies in Global Cardiovascular Innovation Center's Portfolio

4 companies from Global Cardiovascular Innovation Center's portfolio have been acquired.ÌýThe most recent acquisition were Proxy Biomedical in Apr 2022Ìýby .
Here are Global Cardiovascular Innovation Center's portfolio companies that got acquired most recently:
Company
Acquisition Date
First Invested on
First Round of Investment
Round Size
Apr 07, 2022
-
-
-
Oct 31, 2019
-
-
-
Aug 21, 2017
-
-
-
Oct 19, 2016
Jan 15, 2008
Grant (prize money)
$509K

Co-investors of Global Cardiovascular Innovation Center

Over the past 17 years, 33 investors have co-invested in Global Cardiovascular Innovation Center's portfolio companies.

  • Invested before Global Cardiovascular Innovation Center:ÌýAmerica’s Seed Fund, DW Management Services and 7 others have invested in rounds before Global Cardiovascular Innovation Center. There are 1 company where America’s Seed Fund has invested before Global Cardiovascular Innovation Center and 1 company where DW Management Services has invested before Global Cardiovascular Innovation Center.
  • Top Co-investors of Global Cardiovascular Innovation Center:Ìý6 investors entered a company along with Global Cardiovascular Innovation Center. These include investors like RAD BioMed (1 company).
  • Invested after Global Cardiovascular Innovation Center:ÌýA total of 18 investors have invested in Global Cardiovascular Innovation Center's portfolio after their investments. Top Investors include (1 company) and Broadview Ventures (1 company).

Recent News related to Global Cardiovascular Innovation Center

•
MassDevice•Jul 16, 2018•Vectorious Medical Tech, Israel Innovation Authority, , Broadview Ventures and 3 others
•
PR Newswire•Apr 03, 2018•Boston Scientific, , Global Cardiovascular Innovation Center, Jumpstart
•
NoCamels•Feb 25, 2015•Vectorious Medical Tech, RAD BioMed, Global Cardiovascular Innovation Center
•
Juventas Therapeutics•Jul 17, 2012•Juventas Therapeutics, Triathlon Medical Ventures, New Science Ventures, Fletcher Spaght and 5 others
•
GEN•Jan 15, 2008•Arteriocyte, Global Cardiovascular Innovation Center
•
PR Newswire•Vectorious Medical Tech, RAD BioMed, Global Cardiovascular Innovation Center

FAQ's about Global Cardiovascular Innovation Center

ÃØÃÜÑо¿Ëù powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USPalo Alto NetworkMaersk GrowthFujitsuTenityStanford